Objective To investigate the relationship between the characteristic changes and prognosis of the patients with mild cognition impairment (MCI). Methods The methods of clinical memory test, word and phrase fluency test, word immediate recall and word delayed recall test were used in a three-year follow-up research with 14 patients with MCI and 18 healthy elderly individuals. Results Compared to healthy elderly subjects, the scores of the word delayed recall in the patients with MCI were significantly deterioration in the second year of follow up (P

60 years old) in a community of Beijing were investigated by telephone visit, physical examination and Doppler examination. The rates of hypertension, coronary artery disease, diabetes and stroke were evaluated according to the patient whether had PAOD. Results Among 1730 people, 263 cases were diagnosed as POAD. The prevalence of hypertension, coronary heart disease, diabetes and stroke in PAOD population (59.3%,40.3%,29.3% and 22.3%) was higher than those in non-PAOD population (48.1%,32.6%,23.0%and 15.2%)( P

Objective: To study the effect of active attention with/without target counting on event-related potentials (ERPs) Method: ERPs were elicited by non-target (750 Hz, 80%) and target (2000 Hz, 20%) stimuli in an auditory oddball paradigm for 18 healthy young subjects Results:Compared to the active attention with target counting manner, P3 amplitude was significantly smaller when without target counting (P

Objective To evaluate the efficacy and safty of BaileMian capsulae on treatment of insomnia in aged people. Methods 40 aged people with insomnia were randomly divided into the research group (BaileMian capsule group,n= 20) and the control group (Zaorenanshen capsule group,n=20) treated for 14 days.The clinical effects were esti- mated with SDRS before and after 1 w and 2 w treatment.Results The total SDRS scores after treatments in both groups were significantly decreased comparing with scores before treatments respectively (P

Primary age-related tauopathy (PART) is one of neurodegenerative diseases in the very old people. PART clinically resembles Alzheimer′s disease and its definite diagnose needs pathological identification of neurofibrillary tangles with or without amyloid plaques in the brain. This article reviews the historical evolution, clinical manifestation, pathology and diagnosis of PART in order to provide new insights.

BACKGROUND: As the second anti-Alzheimer disease drug approved by Food and Drug Administration(FDA), donepezil (Aricept) has been applied in European and American market. According to the regulation of Health Ministry of China, it needs conducting clinical trial of multiple center nationwide in order to come into Chinese market.OBJECTIVE: To evaluate the efficiency and safety of donepezil on treating mild and moderate Alzheimer disease (AD).DESIGN: Randomized, single blind and placebo control prospective study based on patients.SETTING: Neurological Department of Peking Hospital and Neurological Department of the 301 Hospital of Chinese PLA, and ect.PARTICIPANTS: Totally 188 patients with mild and moderate AD[with mini-mental state examination(MMSE) score of 10 to 24 points] from 15 big hospitals of Beijng, Shanghai and Guangzhou were conducted 12 weeks'clinical trial, among which 89 cases were of single blind and placebo control study while 99 cases were of self-controlled study. All the cases met the AD diagnostic standard of clinical neurology, linguistic dysfunction and stroke(NINCDS-ADRDA) and the 4th edition of Statistic Manual (DSM-IVR).INTERVENTIONS: Donepezil (5 rmg/tablet, ip, 5 rmg/time) or placebo with same color, shape, flavor and size with donepezil ( ip, 1 tablet/time)was taken orally for 12 consecutive weeks.MAIN OUTCOME MEASURES: MMSE, clinical dementia rating scale(CDR), activities of daily life scale(ADL), biochemical parameters, electrocardiograph(ECG) and chest x-ray were conducted once every 4 weeks before and after treatment.RESULTS: The random, single blind and placebo control study showed that the score of MMSE, CDR and ADL was greatly improved in donepezil group after 12 weeks' treatment when comparing with placebo group(P ＜ 0. 01,0.05, 0.01 ). Self-controlled study showed that the score of MMSE, CRD and ADL in donepezil group after 12 weeks' treatment increased 3.5, 0.6 and 7.1 points respectively compared with those before treatment(P ＜ 0.01,0.05, 0.01 ) . The score of MMSE was already improved in the 4th week of treatment. Among the 145 patients who took donepezil, 7 cases(4.8% )experienced side effect of mild cholinergic excitability. In the placebo group,2 of the 43 cases appeared dizziness and nausea. There was no difference between two groups( P ＞ 0.05).CONCLUSION: Donepezil can effectively treat mild and moderate AD patients and improve their cognitive functions, dementia level and daily living abilities with good tolerance and high safety.

Objective To study the relationship among Alzheimer-like neuropathologic changes and their relationship with age and sex. Methods From January 1,1986 to April 1,2000,all autopsy caus of non-demented individuals ≥40 years of age in the General Hospital of PLA were examined for Alzheimer-like neuropathologic changes in hippocampus.There were 41 female and 97 male. Senile plaques(SP),neurofibrillary tangles(NFT) were identified with modified Palmgren-stain method. Hirano bodies(HB) or granulovacuolar degeneration(GVD) were identified with HE stain methods. Results About 40% patients had Alzheimer-like neuropathological changes in hippocampus. There was a highly significant correlation was found between the incidence and severity of SP?NFT?Hirano or GVD and patients' age in the CA1 field of the hippocampus, but no significant difference between male and female. There was a strong correlation among the prevalence and numerical densities of these four types of Alzheimer-like changes. Conclusions Alzheimer-like neuropathologic changes were mainly distributed in CA1 of hippocampus. In CA1 they had relationship with age, but no relationship with sex and they had correlation each other.

Objective To assess excessive daytime sleepiness (EDS) in patients with Parkinson's disease (PD) using the Epworth Sleepiness Scale (ESS) and to examine the main cause of EDS. Methods 96 consecutive PD patients and 98 age-matched healthy controls participated in the study. The severity of the disease was evaluated by Hoehn and Yahr stage (H&Y) and Unified Parkinson's disease Rating Scale-Ⅲ (UPDRS-Ⅲ), and information of anti-PD medications was collected. The correlations among EDS and age, severity of PD, PQSI score, duration of illness and medications were analyzed. Results The mean ESS score was 6.05 (S.D.3.83) in PD patients and 4.24 (S.D.3.21) in controls (P

Objective Inflammation is considered as a driving force in the pathogenesis of Alzheimer's disease. We study the inhibitory effects of indomethacin on production of nitric oxide (NO) in ?-amyloid 1-42 stimulated microglia in vitro, in order to explore the role of ?-amyloid and microglia in the pathogenesis of Alzheimer's disease, and that admimistration of anti-inflammatory drugs might be an effective therapeutic modality. Methods We cultured murine microglia BV-2 cells to serve as the model of microglia for experimentation in vitro. Indomethacin in different concentrations (10 -9 , 10 -8 , 10 -7 , 10 -6 and 10 -5 mol/L) was added separately without or with ?-amyloid 1-42 20?mol/L, and culture was continued for 12h. The production of nitric oxide (NO) and the activity of inducible nitric oxide synthase (iNOS) in the supernatant of culture were determined. iNOS mRNA expression was assessed by RT-PCR. Results There was no effect in the production of NO and the activity of iNOS in BV-2 cells incubated with indomethacin alone. Indomethacin could inhibit NO production and lower iNOS activity and iNOS mRNA expression after microglia were stimulated by ?-amyloid 1-42, and the inhibitory effect was obvious at the concentration of 10 -7 -10 -5 mol/L. Conclusions As a conventional non-steroidal anti-inflammatory drug (NSAIDs), indomethacin can inhibit NO production, decrease iNOS activity and iNOS mRNA expression in BV-2 microglia after being stimulated by ?-amyloid 1-42 in vitro. The results suggest that the mechanism by which indomethacin might be beneficial in treatment of AD might be due to the inhibition of NO production from microglia, blocking the inflammatory cascade reaction to ameliorate injury to neuron. As an effective model in vitro, BV-2 microglia are valuable in the study of Alzheimer's disease.

Objective Some researches showed that vascular risk factors might be related to Alzheimer's disease (AD), but there are still disputes among neurologists. Therefore, it was our hope to explore the possible relationship between AD and vascular factors. Methods A case-control study including 155 cognitive normal controls and 91 possible AD patients in Chinese PLA General Hospital was conducted. The patients and controls were matched for gender, occupation and education level. The relationship between AD and vascular factors was analyzed by Logistic model. The level of statistical significance of differences in single factor and multivariate analysis was P